Search

everythinglearnresearchcommunity

for

Search:↓

Steroid hormones can help treat aging issues and improve health in elderly people.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Certain topical drugs can regrow hair in mice.

Alopecia areata is an autoimmune disease causing hair loss, with treatments often ineffective but new options are being researched.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.